Details
| Stereochemistry | ABSOLUTE |
| Molecular Formula | C23H36O2 |
| Molecular Weight | 344.5307 |
| Optical Activity | UNSPECIFIED |
| Defined Stereocenters | 6 / 6 |
| E/Z Centers | 1 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
CC[C@H](C)[C@H]1CC[C@@H]2[C@]1(C)CCC\C2=C/C=C3C[C@@H](O)C(=C)[C@H](O)C3
InChI
InChIKey=QSLUXQQUPXBIHH-YHSKWIAJSA-N
InChI=1S/C23H36O2/c1-5-15(2)19-10-11-20-18(7-6-12-23(19,20)4)9-8-17-13-21(24)16(3)22(25)14-17/h8-9,15,19-22,24-25H,3,5-7,10-14H2,1-2,4H3/b18-9+/t15-,19+,20-,21+,22+,23+/m0/s1
| Molecular Formula | C23H36O2 |
| Molecular Weight | 344.5307 |
| Charge | 0 |
| Count |
|
| Stereochemistry | ABSOLUTE |
| Additional Stereochemistry | No |
| Defined Stereocenters | 6 / 6 |
| E/Z Centers | 1 |
| Optical Activity | UNSPECIFIED |
Originator
Approval Year
PubMed
| Title | Date | PubMed |
|---|---|---|
| Topical becocalcidiol for the treatment of psoriasis vulgaris: a randomized, placebo-controlled, double-blind, multicentre study. | 2007-08 |
|
| Effect of 2-methylene-19-nor-(20S)-1 alpha-hydroxy-bishomopregnacalciferol (2MbisP), an analog of vitamin D, on secondary hyperparathyroidism. | 2007-05 |
Patents
Sample Use Guides
In Vivo Use Guide
Sources: https://www.ncbi.nlm.nih.gov/pubmed/17596167
One hundred and eighty-five subjects with chronic plaque-type psoriasis affecting 2-10% of their body surface area took part in a multicentre, double-blind, parallel-group, vehicle-controlled, randomized controlled trial comparing topical application of placebo, becocalcidiol 75 microg g(-1) once daily (low dose) or becocalcidiol twice daily (high dose) for 8 weeks.
Route of Administration:
Topical
| Substance Class |
Chemical
Created
by
admin
on
Edited
Mon Mar 31 18:23:19 GMT 2025
by
admin
on
Mon Mar 31 18:23:19 GMT 2025
|
| Record UNII |
N75R59YD0F
|
| Record Status |
Validated (UNII)
|
| Record Version |
|
-
Download
| Name | Type | Language | ||
|---|---|---|---|---|
|
Preferred Name | English | ||
|
Official Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Common Name | English |
| Classification Tree | Code System | Code | ||
|---|---|---|---|---|
|
NCI_THESAURUS |
C39713
Created by
admin on Mon Mar 31 18:23:19 GMT 2025 , Edited by admin on Mon Mar 31 18:23:19 GMT 2025
|
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
300000034081
Created by
admin on Mon Mar 31 18:23:19 GMT 2025 , Edited by admin on Mon Mar 31 18:23:19 GMT 2025
|
PRIMARY | |||
|
N75R59YD0F
Created by
admin on Mon Mar 31 18:23:19 GMT 2025 , Edited by admin on Mon Mar 31 18:23:19 GMT 2025
|
PRIMARY | |||
|
CHEMBL2104955
Created by
admin on Mon Mar 31 18:23:19 GMT 2025 , Edited by admin on Mon Mar 31 18:23:19 GMT 2025
|
PRIMARY | |||
|
QQ-21
Created by
admin on Mon Mar 31 18:23:19 GMT 2025 , Edited by admin on Mon Mar 31 18:23:19 GMT 2025
|
PRIMARY | |||
|
DB04891
Created by
admin on Mon Mar 31 18:23:19 GMT 2025 , Edited by admin on Mon Mar 31 18:23:19 GMT 2025
|
PRIMARY | |||
|
C77083
Created by
admin on Mon Mar 31 18:23:19 GMT 2025 , Edited by admin on Mon Mar 31 18:23:19 GMT 2025
|
PRIMARY | |||
|
DTXSID50415362
Created by
admin on Mon Mar 31 18:23:19 GMT 2025 , Edited by admin on Mon Mar 31 18:23:19 GMT 2025
|
PRIMARY | |||
|
8561
Created by
admin on Mon Mar 31 18:23:19 GMT 2025 , Edited by admin on Mon Mar 31 18:23:19 GMT 2025
|
PRIMARY | |||
|
524067-21-8
Created by
admin on Mon Mar 31 18:23:19 GMT 2025 , Edited by admin on Mon Mar 31 18:23:19 GMT 2025
|
PRIMARY | |||
|
5289547
Created by
admin on Mon Mar 31 18:23:19 GMT 2025 , Edited by admin on Mon Mar 31 18:23:19 GMT 2025
|
PRIMARY |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
|
PARENT -> DERIVATIVE |
|
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
|
ACTIVE MOIETY |
|